CCNK and lung carcinoma: To exclude any off-target effects of Cyclin K siRNA and to further confirm the roles of Cyclin K in lung cancer, we generated a Cyclin K siRNA resistant plasmid (SFB-Cyclin K-R) (Figure 8A).